SCHEMBL14097699

SCHEMBL14097699

CCNC(=N)Nc1nc2cc(-c3cncnc3)cc(C)c2o1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14395390 0.86 ABL1 (0.41) —
SCHEMBL14097684 0.74 ABL1 (0.41) —
SCHEMBL14097686 0.73 ABL1 (0.40) —
SCHEMBL14097698 0.72 ABL1 (0.39) —
SCHEMBL14097687 0.69 MAPK8 (0.41) —
SCHEMBL14097693 0.68 ABL1 (0.43) TP53MAPT
SCHEMBL14097697 0.67 PIK3CA (0.36) —
SCHEMBL14097683 0.62 ABL1 (0.52) —
SCHEMBL14097694 0.61 ABL1 (0.52) —
SCHEMBL14097711 0.60 ABL1 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
Send feedback